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Discovered in late 1817, cadmium is currently one of the most important occupational and environmental 
pollutants. It is associated with renal, neurological, skeletal and other toxic effects, including reproductive 
toxicity, genotoxicity, and carcinogenicity. There is still much to ﬁ nd out about its mechanisms of action, 
biomarkers of critical effects, and ways to reduce health risks. At present, there is no clinically efﬁ cient 
agent to treat cadmium poisoning due to predominantly intracellular location of cadmium ions. This article 
gives a brief review of cadmium-induced oxidative stress and its interactions with essential elements zinc 
and magnesium as relevant mechanisms of cadmium toxicity. It draws on available literature data and our 
own results, which indicate that dietary supplementation of either essential element has beneﬁ cial 
effect under condition of cadmium exposure. We have also tackled the reasons why magnesium 
addition prevails over zinc and discussed the protective role of magnesium during cadmium exposure. 
These ﬁ ndings could help to solve the problem of prophylaxis and therapy of increased cadmium 
body burden.
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Detailed historical information on cadmium 
(Cd) has recently been reviewed by Nordberg (1). 
A German chemist Friedrich Strohmeyer discovered 
this metal in 1817. Forty years later, acute 
gastrointestinal and respiratory symptoms were 
observed in persons using cadmium carbonate 
powder as a polishing agent. Increased occupational 
exposure to Cd was observed after 1912, when the 
production of nickel-cadmium (Ni-Cd) batteries 
started in Sweden. Further investigations conﬁ rmed 
the toxic effects of Cd on the lungs, kidneys, and 
bones. Damage to the lungs in Cd-exposed workers 
was reported as early as the 1930s, while Nicaud 
observed osteomalacia and Friberg proteinuria and 
emphysema in the 1940s (1, 2).
However, it was Itai-itai (ouch-ouch) disease 
that demonstrated the dangerous dimensions of Cd 
as an environmental pollutant. It was an endemic 
bone disease characterised by fractures and severe 
pain related to exposure to Cd that occurred after 
World War II in Toyama Prefecture in Japan (1, 3). 
The clinical symptoms and signs of osteomalacia 
and osteoporosis, femoral pain, lumbago and skeleton 
deformations, renal tubular dysfunction, immune 
deﬁ ciencies, apathies, malabsorption, and anaemia 
were observed mostly in multiparous women living 
along the contaminated Jinzu River basin. Elevated 
levels of Cd were found in patients’ urine. In 1968, 
the Japanese government acknowledged that the 
disease was as an environmental disease related to 
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Cd-contaminated water released from a mine into 
the Jinzu River, which was used to irrigate rice 
fields. The disease was the result of several 
unfavourable factors: consumption of Cd-
contaminated water and rice, low dietary intake of 
proteins, and essential element deﬁ ciencies due to 
multiple pregnancies. High Cd exposure levels were 
associated with adverse effects on the skeleton 
through toxic effects on kidney, and also, as was 
conﬁ rmed later, by direct Cd effects on bone tissue. 
For the ﬁ rst time, Cd pollution was shown to have 
severe consequences on human health. Subsequently, 
interest in Cd, initiated by Friberg’s observations 
of renal damage in occupationally exposed workers, 
arrived on the scientiﬁ c scene (2).
The discovery of a Cd-containing protein from 
horse kidney by Margoshes and Vallee (4) in 1957 
marked the beginning of research of this low-
molecular weight, cysteine-rich protein named 
metallothionein by Kägi and Vallee (5). Further 
studies confirmed the important role of 
metallothionein in the toxicokinetics and 
toxicodynamics of Cd and identiﬁ ed the kidney as 
one of the critical organs of Cd toxicity (6).
Cadmium is classiﬁ ed as a toxic element without 
any beneﬁ cial role in human physiology. Several 
studies have shown the role of Cd as an essential metal 
in ruminants (7). It was recently reported that some 
marine algae contain a form of the enzyme 
carboanhydrase with cadmium instead of zinc (Zn) in 
their active sites (8).
Cadmium has also found its place in the rapidly 
expanding ﬁ eld of nanotechnology, which is therefore 
likely to become yet another source of its toxicity. 
Cadmium-containing nanoparticles, known as CdSe 
or CdTe-core quantum dots, have numerous biomedical 
applications, especially in the diagnosis of cancer, due 
to their unique optical and electrical properties. 
Despite their potential to revolutionise medical 
therapy, Cd-containing quantum dots are potentially 
toxic and their use presents substantial risk (9-12).
Over the last 50 years, the awareness and 
concern about Cd toxicity have resulted in a vast 
literature on this matter. Cadmium was called “the 
metal of the 20th century”. Future investigations 
will continue in order to further elucidate its mode 
of actions and their mechanism(s), identify 
biomarkers of critical effects, and to develop 
preventive and therapeutic strategies to decrease 
Cd body retention (e.g. 13).
This article gives a brief review of Cd research 
until now, including our own, with a focus on the 
current signiﬁ cance of cadmium and its modes of 
action through induction of oxidative stress and 
interactions with selected essential elements.
OCCUPATIONAL AND 
ENVIRONMENTAL EXPOSURE
TO CADMIUM
Cadmium is ubiquitous environmental and 
occupational pollutant. Today it is mainly used in the 
manufacture of nickel–cadmium batteries, pigments, 
and plastic stabilizers, whereas applications in alloys, 
solders and electroplating show a decreasing trend. 
Both natural and anthropogenic activities 
signiﬁ cantly contribute to environmental quantities 
of Cd. Natural sources of Cd include volcanic activity, 
forest fires, and soil particles carried by wind. 
Anthropogenic sources are copper (Cu) and nickel 
(Ni) smelting and fossil fuel combustion. Occupational 
exposure to Cd usually occurs in mines, in the 
production of batteries and pigments containing Cd, 
in the production and processing of Cd, its alloys, and 
compounds, and in recycling electronic waste. The 
leading producers of this metal, mostly for Ni-Cd 
batteries, are China, Japan, and Korea. The last few 
decades have seen a significant drop in the 
production and use of Cd, especially in the United 
States and the European Union. However, Cd 
continues to be a major health problem, mostly 
because of its long half-life (15 to 20 years) and 
persistence in the environment and a variety of 
tissues (14-17).
Air and drinking water Cd levels are not alarming; 
they keep around 0.04 μg m-3 and below 1 μg L-1, 
respectively (16). Therefore, air Cd does not 
signiﬁ cantly contribute to the total dose of Cd 
absorbed by the body, except in people living near 
or working in metal industries. Exposure of general 
population to Cd should be kept as low as possible. 
The EU has proposed that urinary Cd concentration 
should be below 0.66 μg g-1 of creatinine (16), 
which reﬂ ects the recent ﬁ ndings on the adverse 
effects of low-level Cd exposure. In a priority list 
of hazardous substances established by the US 
Comprehensive  Environmenta l  Response , 
Compensation, and Liability Act, Cd ranks seventh 
(17).
Cadmium does not degrade in the environment 
and can enter the food chain, which steadily increases 
the risk of human exposure. Cadmium is present in 
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almost all kinds of food. Its concentration varies 
greatly with the type of food and the level of 
contamination. Human activities such as mining, 
waste incineration, fossil fuel combustion, and 
application of phosphate fertilisers and sewage 
sludge that contain Cd signiﬁ cantly contribute to 
the contamination of soils and consequently, 
cultivated plants. Wheat and rice, green leafy 
vegetables, and potatoes contain higher concentration 
than other foods from plants and account for more 
than 80 % of Cd intake by food. Cadmium is also 
present in high concentrations in ﬁ sh and sea food 
(molluscs and crustaceans) and also in offal 
products. Adults across Europe are exposed to Cd 
levels nearing the tolerable weekly intake (TWI) 
of 2.5 μg kg-1 b. w. Cadmium TWI can also be 
exceeded in other subgroups such as children, 
vegetarians, and people who are occupationally 
exposed or live in polluted areas (16).
Beside food, cigarette smoke is the largest source 
of non-occupational exposure, because Cd tends to 
accumulate in tobacco leaves, and between 40 % 
and 60 % of inhaled Cd can enter blood circulation. 
Cadmium content in cigarettes may vary with 
cigarette brand, but the usual content per cigarette 
ranges between 1 μg and 2 μg. While the average 
person absorbs around 1 μg of Cd through food per 
day, smokers that smoke one pack of cigarettes per 
day can absorb additional 1 μg to 3 μg of Cd and thus 
heavy smokers have more than double the Cd body 
content (14, 15).
CADMIUM TOXICITY
AND CARCINOGENICITY
The ﬁ rst reported human adverse health effect 
related to Cd was lung damage in exposed workers. 
Subsequent studies identiﬁ ed the kidney as the critical 
organ of Cd toxicity, although Cd also causes adverse 
effects on the liver, lungs, pancreas, bones, reproductive 
organs, placenta, and hematopoietic, nervous, and 
cardiovascular systems (1, 2). In a recent paper 
Bhattacharyya (18) gave an overview on data that 
confirm low-level Cd-induced osteotoxicity with 
decreased bone mineral density and calciotropic 
hormone levels. The Third US Health and Nutrition 
Examination Survey (NHANES III) (19), which 
included 8722 US citizens over the age of 40, showed 
a signiﬁ cant association between Cd urine content and 
myocardial infarction. Findings of abnormal fasting 
glucose and diabetes suggest that Cd may cause pre-
diabetes and diabetes mellitus in humans (20). 
Furthermore, Cd disrupts the endocrine function by 
binding to cellular steroid receptors and can have 
oestrogen-like and androgen-like activity (21). 
Occupational exposure to Cd has been associated with 
the lung, pancreas, prostate, breast, and kidney cancer 
(22, 23). The International Agency for Research on 
Cancer (IARC) and the US National Toxicology 
Program classiﬁ ed Cd as human carcinogen (category 
1) (24, 25). As reviewed by Nawrot et al. (26) this 
classiﬁ cation is based on evidence of carcinogenicity 
collected in three lines, that is, epidemiological 
evidence, in vivo and in vitro studies. A relationship 
between Cd exposure and the occurrence of lung 
cancer was found in exposed workers who had a 20 % 
higher risk of lung cancer than control workers. A 
prospective cohort study conducted in an area close 
to three zinc smelters showed an association between 
lung cancer incidence and Cd exposure; a twofold 
increase in 24-h urinary Cd excretion corresponded 
to a 70 % greater risk of lung cancer. Furthermore, the 
pulmonary system is a target of Cd-associated 
carcinogenesis. Lastly, several studies provide 
evidence that cadmium may have carcinogen potential 
in vitro.
There is no definite evidence that Cd causes 
prostate cancer and only three out of 11 cohort studies 
have found a positive association (27). McElroy et al. 
(22) reported about high risk of breast cancer in 
women that correlated with the level of exposure. 
Correlations were also found between Cd levels and 
age-adjusted prostate and breast cancer incidence in 
Europe (28).
New methods such as differential gene and protein 
expression proﬁ ling in experimental animals exposed 
to Cd may help to better understand the mechanisms 
involved in Cd toxicity and carcinogenesis. This 
approach can help to develop molecular markers of 
Cd exposure, toxicity, and carcinogenesis that may be 
used in epidemiological studies for predicting the 
incidence of cancer in humans (29).
MECHANISMS INVOLVED
IN CADMIUM TOXICITY AND 
CARCINOGENICITY
Over the last few decades, substantial efforts have 
been made to clarify the mechanisms of Cd toxicity. 
However, the precise mechanism(s) underlying 
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particular toxicity remain unclear. The present 
knowledge, based primarily on in vivo and in vitro 
studies, suggests that Cd may cause numerous 
cytotoxic and metabolic effects that have not been 
sufﬁ ciently recognised, such as changes in enzyme 
activity, changes in proteins with sulphydryl groups 
(thioneins), induction of oxidative stress and apoptosis, 
changes in the structure and/or function of cell 
membranes, changes in DNA structure and altered 
gene expression, inhibition of ATP production in 
mitochondria, and interaction with Zn, Cu, Ca, Se, 
and other essential metals (30-32).
Role of cadmium in oxidative stress induction
The ﬁ rst evidence of increased lipid peroxidation 
(LPO) in mice hepatocytes co-cultured with Cd was 
given by Müller (33). The author described Cd-induced 
production of reactive oxygen species (ROS) through 
interaction with critical subcellular sites such as 
mitochondria, peroxisomes, and microsomes, that 
resulted in the generation of free radicals and LPO in 
subcellular membranous structures. Production of ROS 
has been reported later in a variety of cell culture 
systems, as well as in intact animals via all routes of 
exposure (34-37). We also found early signs of 
oxidative stress in the liver of mice exposed to a single 
oral Cd dose (20 mg kg-1 b. w. in the form of CdCl2) 
through increased LPO level, expressed as 
malondialdehyde (MDA) after 6 h, 12 h, and 24 h (38). 
Since Cd has no redox activity, it may enhance ROS 
production by suppressing free-radical scavengers such 
as glutathione (GSH) and by inhibiting detoxifying 
enzymes such as superoxide dismutase, catalase, and 
GSH peroxidase, and/or through other indirect 
mechanisms (39). The ways in which Cd can induce 
the formation of reactive species are summarised in 
Figure 1. Available data conﬁ rm that the formation of 
free radicals such as superoxide ion, hydrogen 
peroxide, and hydroxyl radicals involves depletion of 
GSH and changes in the activity of antioxidant 
enzymes (40). Our recent ﬁ ndings (41) showed that an 
acute oral Cd dose (20 mg Cd kg-1 b. w.) signiﬁ cantly 
decreased the glutathione (GSH) content in mice liver 
4 h, 6 h, and 12 h after Cd administration and increased 
GSH in the kidney after 12 h, 24 h, and 48 h, but did 
not cause signiﬁ cant GSH changes in the testis. A two-
week oral Cd exposure (at dose of 10 mg kg-1 b. w. of 
Cd given as aqueous solution of CdCl2) lowered renal 
levels and increased liver and testicular levels of GSH. 
These results, together with related ﬁ ndings of other 
authors, show that the effect of Cd on GSH tissue levels 
varies with animal species, dose, route, and duration 
of exposure. In general, acute exposure to metals 
decreases GSH levels due to the formation of metal-
GSH complexes and/or consumption by the GSH-
peroxidase under oxidative stress induced by metals.
Figure 1 Pathways of Cd-induced generation of reactive oxygen species (adapted from ref. 39 by Danijela Đukić-Ćosić). 
Cadmium impairs enzyme activity of antioxidative defence system (superoxide dismutase, SOD; catalase, CAT; glutathione 
peroxidase, GSH-Px; glutathione-S-transferase, GST; gluathione reductase, GR) and of the non-enzymatic component glutathione, 
GSSG and GSH.
Cadmium also elevates the levels of Fenton metals (Fe3+, Cu2+), which can break down hydrogen peroxide, H2O2 to a reactive 
hydroxyl radical, OH·.
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Casalino et al. (42) have proposed yet another 
mechanism of Cd-induced ROS production via iron 
(Fe). Cadmium may displace Fe from various 
cytoplasmic and membrane proteins and consequently, 
increased concentration of ionic Fe stimulates ROS 
production in tissue. This is in agreement with our 
recent ﬁ ndings, which clearly show that acute and 
subacute Cd exposures change Fe content in the liver 
of mice (38). The results of this study also indicate 
that Cd affects MDA levels in a time-dependent 
manner. The observed MDA levels positively 
correlated with Fe in the liver. Oral exposure to a single 
dose of Cd (20 mg kg-1 b. w.) signiﬁ cantly increased 
LPO in the liver at 6 h, 12 h, and 24 h, and liver Fe 
after 4 h and 6 h up to 110 % of control level. However, 
in mice orally exposed to Cd for two weeks (10 mg 
kg-1 b. w. in form of CdCl2 in aqueous solution), we 
found liver Fe reduced by 80 % and MDA by 74 %.
There are several other proposed mechanisms of 
Cd-induced oxidative stress. One of these is Cd-
induced inﬂ ammation in the liver. Kupffer cells are 
activated in response to Cd overload and produce 
inﬂ ammatory mediators such as IL-1β, TNF-α, IL-6, 
and IL-8, which in turn stimulate generation of free 
radicals in the liver (43). It has also been suggested 
that mitochondria are an important target of Cd 
toxicity (44).
When it comes to ROS production, the results of 
long-term exposure to low levels of Cd depend on 
experimental conditions such as dose, time intervals 
of oxidative stress evaluation, and animal species 
studied. It seems that ROS production has an important 
role in chronic Cd nephrotoxicity (45), immunotoxicity 
(46), and carcinogenesis (47). On the other hand, 
chronic exposure to Cd often elevates tissue GSH, 
without elevating tissue LPO levels (37, 45). This is 
conﬁ rmed by our own results (38), which showed 
initial increase in liver LPO and Fe levels 24 h after 
a single oral dose, which dropped after repeated Cd 
dosing. Prolonged Cd exposure through drinking water 
also caused a two-phase ROS response. At the 
beginning, ROS production rose, only to drop back to 
normal after eight weeks of exposure (48). It has been 
shown that ROS production does not play an essential 
role in chronic Cd-induced malignant transformation 
in rat liver cells (49).
Interactions between cadmium and essential 
elements
It is well known that Cd interferes with the 
biokinetics and biological roles of many essential 
metals and metalloids such calcium (Ca), magnesium 
(Mg), sodium (Na), potassium (K), Zn, Cu, Fe, 
manganese (Mn), selenium (Se), molybdenum (Mo), 
trivalent chromium (Cr), cobalt (Co), boron (B), and 
other (30-32). However, the exact mechanisms 
involved in these interactions have not been entirely 
identiﬁ ed.
Cadmium and Zn interactions probably are one of 
the most recognised metal-metal interactions due to 
increasing environmental Cd exposure of the general 
population and concomitant widespread Zn deﬁ ciency 
in the world (14-17, 50). Since Zn is a co-factor in 
numerous enzymes and regulatory proteins, including 
the enzymes of DNA and RNA synthesis and repair, 
Cd-induced disturbances in Zn homeostasis may have 
serious consequences on cell growth, development, 
and their functions. Because these two transitional 
metals are similar (both belong to the group IIb of the 
periodic table and form tetrahedral complexes) they 
compete for the same binding sites and/or ligands in 
biological systems.
A number of studies including our own (51-55) 
have shown that Cd disrupts Zn homeostasis. In turn, 
certain Cd-induced toxic effects, such as adverse 
reproductive and perinatal effects, may be ampliﬁ ed 
when Zn is depleted. Osman et al. (56) reported that 
multiparae, cigarette smokers in particular, run the 
highest risk of prenatal Cd toxic effects, which are 
associated with low Zn concentrations in serum, 
placenta, and cord blood. Exposure of rats to Cd 
lowered Zn levels in foetal tissues, accompanied by 
reduction of Zn metalloenzyme activities in both 
maternal and foetal tissues, which may be responsible 
for adverse reproductive outcomes (57). Our recent 
study on rabbits (58) has shown that prolonged oral 
exposure to Cd (10 mg kg-1 b. w. per day during four 
weeks) signiﬁ cantly lowered Zn in blood and nine 
organs.
Interactions between Cd and Mg have been less 
investigated than interactions with other essential 
metals, regardless of the fact that Mg has an 
outstanding physiological and biochemical role. 
Literature data and our own results suggest that Cd 
interferes with Mg absorption in the gastrointestinal 
tract and affects its homeostasis as well. We found 
altered Mg content in the organs of rabbits after 
prolonged Cd exposure (58, 59). Our new and yet 
unpublished investigations carried out on mice have 
conﬁ rmed these negative effects of Cd exposure (both 
by single oral dose to 20 mg kg-1 b. w. and 10 mg 
kg-1 b.w. per day during two weeks) on Fe, Zn, Cu, 
and Mg tissue levels.
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More than thirty years ago, Smetana et al. (60) 
suggested that interaction between Cd and Mg might 
play a crucial role in the pathogenesis of idiopathic 
dilated cardiomyopathy. In the blood and urine of these 
patients Cd was increased, Mg decreased, whereas 
other metals (Pb, Zn, Cu, and Fe) were within 
reference range. While trying to determine the lowest 
Cd level in urine that is still associated with tubular 
dysfunction in Japanese women, Ezaki et al. (61) 
discovered that increased urine Cd levels were 
accompanied by increased excretion of Mg.
In spite of signiﬁ cant improvements in occupational 
safety achieved in the last ﬁ fty years, recent literature 
data indicate that Cd exposure levels in certain 
occupational settings still remain as high as those 
reported in the factories of developed countries before 
the 1950s. In our recent study (62) of Ni-Cd factory 
workers in Serbia we determined blood and urine Cd 
levels to see if there were any Cd-induced effects on 
the renal function and concentrations of Zn, Cu Mg 
and Fe in blood and urine. Although we expected them 
to be high, Cd levels kept within the range proposed 
by the World Health Organization (63) for 
occupationally exposed subjects (10 μg L-1 for blood 
and 10 μg g-1 of creatinine in urine). Altered values of 
β2-microglobulin indicated disturbed renal function 
in only a few workers. We also found signiﬁ cantly 
lower concentrations of Mg in blood and of Zn in 
blood and urine.
Taken together, these results and similar reports in 
the ﬁ eld show that Cd interacts with several essential 
elements. In order to prevent adverse health effects, 
exposure to Cd should be as low as possible and 
exposed persons should include essential nutrient 
supplementation in everyday diet.
Interactions between essential elements
and cadmium
Zinc and cadmium interaction
The antagonism between Cd and certain essential 
elements encouraged investigators to evaluate whether 
micronutrients such as Zn may inﬂ uence Cd toxicity. 
Pařizek (64) published ﬁ rst data on beneﬁ cial effects 
of Zn supplementation against Cd toxicity as early as 
1957. Later research of acute Cd exposure showed 
that Zn inhibited Cd transport along the terminal 
nephron segments in rats and vice versa (65). Jacquillet 
et al. (66) confirmed that Zn addition during Cd 
exposure prevented metal-induced changes in rat renal 
functions. Dietary Zn supplementation may also 
prevent Cd-induced disorders in bone turnover. 
Brzóska et al. (67) reported that increased Zn intake 
during moderate or relatively high chronic Cd 
exposure can, at least partly, prevent disorders in bone 
metabolism.
Experimental data show that Zn can have an 
important impact on Cd-induced carcinogenesis as 
well. Waalkes et al. (68) suggested that excess Zn 
intake affected Cd-induced prostate cancer by 
preventing testicular toxicity and maintaining 
testosterone production. Hu et al. (69) explored 
possible mechanisms responsible for Cd-induced 
reproductive toxicity and prostate cancer in relation 
to Zn. They monitored the expression of metallothionein 
genes, proto-oncogenes and tumour-suppressor gene 
p53 in rat prostate and testis, together with changes 
of testosterone level in serum. They showed that Cd-
induced toxicity and the effects of Zn were complex. 
Although both Cd and Zn reduced testosterone, the 
initiation of prostate cancer is rather related to Cd-
induced altered gene expression.
In a recent investigation (70), we exposed rabbits 
to Cd (as CdCl2 in aqueous solution at oral dose of 
10 mg kg-1 b. w. of Cd per day) for four weeks and 
found that concomitant oral supplementation with Zn 
(as ZnSO4 in aqueous solution at dose of 20 mg kg
-1 
b. w. of Zn per day, given 1 h following Cd 
administration) reduced concentrations of Cd in blood 
and kidney (by 60 %) and to a lesser extent in the 
spleen, brain, and bone, in comparison to rabbits 
exposed to Cd only. The decrease in the Cd levels in 
analysed tissues was most probably due to the 
interaction between Zn and Cd in the intestinal lumen, 
where higher Zn content lowered gastrointestinal 
absorption of Cd. Cadmium uptake occurs 
predominantly through Zn-associated co-transport, as 
both ions compete for common binding sites and for 
membrane carriers such as divalent metal transporter-
1 and luminal Zn transporter-1 (71). Our results (70) 
also showed that Zn decreased renal Cd, but did not 
reduce hepatic Cd, probably due to Zn-induced 
synthesis of metallothionein in the liver, which caused 
Cd accumulation in the liver and delayed its 
redistribution to the kidney. Zinc-associated lower Cd 
levels in spleen may be owed to the fact that this organ 
is richly vascularised and these values actually reﬂ ect 
blood Cd levels. Lower Cd brain levels after excessive 
intake of Zn could be explained by the ability of Zn 
to induce metallothionein synthesis, and the Cd-
metallothionein complex can hardly cross the blood-
brain barrier. Recent investigations of the probable 
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protective mechanisms of Zn in Cd-exposed rats 
showed increased Cd levels in the kidney and 
suggested other protective mechanism of Zn action 
than MT synthesis, such as direct antioxidant action 
of Zn and Zn-improved activity of antioxidant 
enzymes (72).
Magnesium and cadmium interaction
Limited experimental data point to beneficial 
effects of Mg against Cd toxicity. Boujelben et al. (73) 
showed that Mg supplementation could reduce both 
organ Cd accumulation and Cd-related LPO. The 
authors found that parenteral Mg supplementation (in 
form of sulphate) was associated with a dose-
dependent reduction in Cd levels in rat kidney, liver, 
and testis and lowered Cd-induced LPO in the liver 
and kidney. In the testis, the protective effect of Mg 
was present only during the early phase of Cd-
exposure.
We investigated the effect of supplemental 
magnesium in mice exposed to Cd (74). While acute 
oral Cd exposure (20 mg kg-1 b. w.) resulted in a 
signiﬁ cant renal Cd increase, pretreatment with Mg 
(40 mg kg-1 b. w) efﬁ ciently lowered kidney Cd levels 
4 h and 6 h after Cd exposure. Similarly, the Cd 
content in the kidney was also elevated following 
two-week Cd exposure (10 mg kg-1 b. w. per os), and 
the effect was diminished by about 30 % in mice 
pretreated with Mg (20 mg kg-1 b. w. per day). These 
results provide evidence that Mg has the ability to 
protect the kidney from Cd accumulation and point to 
the beneﬁ cial effects of Mg supplementation against 
Cd-altered renal Cu and Zn levels (74).
Our further investigation (41) showed that Mg 
pretreatment signiﬁ cantly lowered Cd content not only 
in the kidney (~30 %), but also in the lungs (50 %), 
spleen (~30 %), and testis (~30 %), following two-
week Cd exposure.
Results of our investigation on rabbits (70) exposed 
orally to Cd (as aqueous solution of CdCl2 at dose of 
10 mg kg-1 b. w. per day) for four weeks also showed 
that concomitant Mg supplementation (40 mg kg-1 b. 
w. as an aqueous solution of Mg(CH2COO)2 per day 
given 1 h after Cd administration) had the beneﬁ cial 
effects against tissue accumulation of Cd. Excessive 
intake of Mg reduced blood, kidney, spleen, and bone 
Cd levels for about 30 % in respect to rabbits given 
only Cd. However, we did not observe any relevant 
changes in the lungs, heart, liver, pancreas, muscle, 
and brain. This suggests that Mg modifies Cd 
absorption in the gastrointestinal system by affecting 
the intercellular leak of Cd from intestinal lumen to 
portal blood and thus reduces peripheral blood Cd. 
The effect of Mg supplementation on renal Cd 
retention could be explained by Cd-Mg competition 
during reabsorption. Furthermore, increased Mg in 
the lumen of the distal nephron could disable Cd 
uptake by intercellular transport and promote Cd 
elimination via urine.
THERAPY OF CADMIUM POISONING
No effective therapy of Cd poisoning has yet been 
developed, and currently it only addresses the 
symptoms (14). The most common agents, which have 
been used against heavy metal poisoning since World 
War 2 are chelators, starting with British Anti-Lewisite 
(BAL).  Af ter  the  war,  ca lc ium disodium 
ethylenediaminetetraacetate (CaNa2EDTA), 
deferoxamine, and D-penicillamine were introduced 
in clinical practice (75). However, none of the 
available chelating drugs is effective against poisoning 
with Cd because it quickly enters the tissue and binds 
to metallothioneins (14, 75). Some chelating agents 
such as polyaminocarboxylic acids [e. g. CaNa2EDTA, 
calcium trisodium diethylenetriaminepentaacetate 
( C a N a 3 D T PA ) ,  a n d  z i n c  t r i s o d i u m 
diethylenetriaminepentaacetate (ZnNa3DTPA)], 
carbodithioates, deferoxamine (DFO), N-acetylcysteine 
(NAC), and 2,3-dimercaptosuccinic acid and its esters 
have shown some effectiveness in experimental 
animals when applied very soon after Cd exposure 
(75).
Literature data indicate the protective role of Zn 
supplementation against Cd toxicity, possibly because 
it stimulates metallothionein synthesis and competes 
with Cd for enzyme-binding sites (14, 67, 76-78). In 
addition, some studies have shown favourable effects 
of pretreatment with other essential elements on Cd 
toxicity (79, 80). Supplementation with minerals has 
not yet been approved for clinical use, since it is still 
not clear whether it is effective in subjects with 
adequate essential element intake, or only in Zn- and/
or Ca-deficient individuals Similarly, the role of 
supplementation with antioxidants, such as vitamins 
A, C, or E, has been investigated in experimental 
settings in order to ﬁ nd an effective way to counter 
Cd-induced oxidative stress in tissue (14).
In our recent study of Cd in exposed rabbits (81), 
we determined the effects of increased oral intake 
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of Zn, Cu or Mg on the kinetics of Cd in various 
tissues to assess whether treatment with one of these 
bioelements could be used in prophylaxis and/or 
therapy of Cd poisoning. Rabbits were administered 
Cd by gastric tube (as aqueous solution of CdCl2 at 
dose of 10 mg kg-1 b. w. per day) for four weeks, and 
three groups were supplemented oral Zn, Cu, or Mg 
[as aqueous solutions at doses of 20 mg kg-1 b. w. of 
Zn in the form of ZnSO4;10 mg kg
-1 b. w. of Cu in the 
form of CuSO4; or 40 mg kg
-1 b. w. of Mg in the form 
of Mg(CH3COO)2] one hour after Cd exposure. 
Concentrations of Cd and essential elements were 
determined in blood and urine samples collected at 
different time intervals during the experiment and in 
nine organs (brain, heart, lungs, kidney, liver, spleen, 
pancreas, skeletal muscle, and bone) dissected at the 
end of experiment. Zinc supplementation was 
associated with reduced blood Cd throughout the 
experiment. Signiﬁ cant decreases were also determined 
in the kidney, brain, spleen, and bone. Similarly, Mg 
supplementation signiﬁ cantly reduced Cd in blood, 
kidney, spleen, and bone, without any signiﬁ cant 
changes in urine Cd. Contrary to Zn and Mg, Cu 
supplementation did not reduce Cd levels in blood, 
heart, and liver. These results have conﬁ rmed the 
antagonism between Cd and Mg as well as between 
Cd and Zn, which is similar to our ﬁ ndings on the 
antagonism between Pb and Mg in experimental 
rabbits (82-86).
The effects of either Zn or Mg supplementation on 
Cd concentration and distribution in various tissues 
show similar beneﬁ cial effects on Cd body burden 
reduction in exposed rabbits. Although we found that 
Zn more efﬁ ciently reduced Cd tissue levels, especially 
in the kidney, we propose Mg as a dietary supplement 
of choice for reduction of Cd body burden, as the 
addition of Mg did not disturb either Zn or Cu levels. 
In turn, excessive Zn intake in our studies reduced Mg 
levels in blood and most of the investigated organs 
and increased its elimination via urine (58). Magnesium 
has a wide therapeutic range, and therefore further 
investigations are needed to justify its efﬁ ciency as a 
therapeutic agent against toxic metals, Cd in 
particular.
CONCLUDING REMARKS
AND PROSPECTS
Cadmium is an occupational and environmental 
pollutant whose toxicity was eagerly investigated 
during the last decades. The pervasive nature of Cd 
in the environment and in biological tissues may have 
serious consequences, especially with respect to the 
role of Cd as a human carcinogen. Although the toxic 
effects of Cd are well known, the speciﬁ c mechanisms 
by which it produces its adverse effects have yet to be 
fully investigated. Cadmium can cause oxidative 
stress, which may lead to cytotoxic and carcinogenic 
effects in target organs, and deeper insight into these 
mechanisms can give proper explanations to protect 
exposed population groups. However, there are great 
differences between in vivo and in vitro effects of Cd 
that still need to be addressed in research.
Literature data show that Cd affects the homeostasis 
of essential metals at the cell level. This review has 
focused on results, including our own, showing 
interactions between Cd and bioelements Mg and Zn. 
In general, exposure to Cd reduces the levels of 
essential elements, which may have adverse health 
effects. On the other hand, Mg or Zn supplementation 
has a beneﬁ cial role in reducing Cd body burden and 
could be used for prevention and/or therapy. Years of 
our investigations in the ﬁ eld have conﬁ rmed the 
advantage of Mg over Zn supplementation. New 
research should look deeper into these complex 
interactions, as they go far beyond mere metal 
substitutions and are mediated in part by redox-
sensitive systems acting at the transcriptional and 
transductional levels. A clearer insight into cation 
transporters and their speciﬁ city, cation effects on cell 
membrane transport, intracellular stores of Cd, and 
molecular regulation of homeostasis of essential 
metals might help to explain interactions between Cd 
and essential metals.
Future research should fill in the lacking 
information to be used for environmental and 
human risk assessment. This information might be 
obtained by developing novel biomarkers for early 
detection of Cd-induced toxicity in exposed 
populations, subgroups in particular. Analytical 
methods should be improved by the -omics 
biomarkers and sophisticated biomarkers that keep 
pace with new Cd-exposure scenarios, such as 
exposures to Cd-based nanoparticles.
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Sažetak
JOŠ O TOKSIČNOSTI KADMIJA - S POSEBNIM OSVRTOM NA NASTANAK OKSIDACIJSKOGA 
STRESA I NA INTERAKCIJE S CINKOM I MAGNEZIJEM
Iako je otkriven tek 1817. godine, kadmij je trenutačno jedan od najvažnijih onečišćivača životne i 
radne sredine. Štetno djeluje na bubrege, živčani sustav, kosti, reproduktivni sistem, a ima i 
genotoksične i karcinogene efekte. Nužna su dalja istraživanja vezana za mehanizme njegove 
toksičnosti, biomarkere efekata, kao i načine smanjenja rizika za zdravlje. Osim toga, do danas nije 
otkriven agens eﬁ kasan u terapiji trovanja kadmijem s obzirom na to da je kadmij intracelularni 
kation. U ovom radu dan je sažet pregled važnih mehanizama toksičnosti kadmija, kao što su nastanak 
oksidativnog stresa i interakcije s esencijalnim elementima, cinkom i magnezijem, na osnovi dostupnih 
literaturnih podataka, kao i naših ispitivanja koja upućuju na to da povećani unos navedenih 
esencijalnih elemenata pokazuje pozitivne efekte pri ekspoziciji kadmiju. Obrazložena je prednost 
suplementacije magnezijem pred suplementacijom cinkom i razmatrana preventivna uloga magnezija 
pri intoksikaciji kadmijem. Ovi su rezultati doprinos rješavanju problema proﬁ lakse i terapije trovanja 
kadmijem.
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